Appendix 1.
Writing group member | Employment | Honoraria/speaking/consulting | Speakers’ bureau | Researcha | Fellowship supporta | Ownership/ partnership/ principal/majority stockholder | Stock or stock options | Intellectual property/ royalties | Other |
---|---|---|---|---|---|---|---|---|---|
Niraj Varma, MA, MD, PhD, FACC, FRCP (Chair) | Cleveland Clinic, Cleveland, OH, USA | 1: BIOTRONIK; 1: EP Solutions; 1: Medtronic; 1: MicroPort | None | 1: Boston Scientific; 2: Abbott | None | None | None | None | None |
Nassir F. Marrouche, MD, FHRS (Vice-Chair) | Tulane University School of Medicine, New Orleans, LA, USA | 0: Biosense Webster; 0: BIOTRONIK; 0: Cardiac Design; 0: Medtronic; 1: Preventice | None | 0: Abbott; 0: Boston Scientific; 0: GE Healthcare; 5: Biosense Webster | None | None | None | None | None |
Luis Aguinaga, MD, MBA, PhD, FESC, FACC | Centro Privado de Cardiología, Tucuman, Argentina | None | None | None | None | None | None | None | None |
Christine M. Albert, MD, MPH, FHRS, FACC | Cedars-Sinai Medical Center, Los Angeles, CA, USA | 1: Roche Diagnostics | None | 5: Abbott; 5: NIH; 5: Roche Diagnostics | None | None | None | None | None |
Elena Arbelo, MD, MSci, PhD | Arrhythmia Section, Cardiology Department, Hospital Clínic, Universitat de Barcelona, Barcelona, Spain; Institut d’Investigacións Biomèdiques August Pi i Sunyer (IDIBAPS), Barcelona, Spain; Centro de Investigación Biomédica en Red de Enfermedades Cardiovasculares (CIBERCV), Madrid, Spain | 1: Biosense Webster | None | None | None | None | None | None | None |
Jong-Il Choi, MD, PhD, MHS | Korea University Medical Center, Seoul, Republic of Korea | None | None | None | None | None | None | None | None |
Mina K. Chung, MD, FHRS, FACC | Cleveland Clinic, Cleveland, OH, USA | 2: ABIM | None | 5: AHA; 5: NIH | None | None | None | 1: Elsevier; 1: UpToDate | 0: ACC (EP Section Leadership Council member); 0: AHA (Chair, ECG & Arrhythmias Committee; Member, Clinical Cardiology Leadership Committee; Member, Committee on Scientific Sessions Programming); 0: Amarin (Data monitoring committee member); 0: BIOTRONIK (EPIC Alliance steering committee member); 2: AHA (Associate Editor, Circulation: Arrhythmia and Electrophysiology) |
Giulio Conte, MD, PhD | Cardiocentro, Lugano, Switzerland | None | None | 5: Boston Scientific; 5: Swiss National Science Foundation | None | None | None | None | None |
Lilas Dagher, MD | Tulane University School of Medicine, New Orleans, LA, USA | None | None | None | None | None | None | None | None |
Laurence M. Epstein, MD, FACC | Northwell Health, North Shore University Hospital, Manhasset, NY, USA | 1: Abbott; 2: Medtronic; 2: Spectranetics Corporation | None | None | None | None | None | None | 2: Boston Scientific (Clinical Events Committee) |
Hamid Ghanbari, MD, FACC | University of Michigan, Ann Arbor, MI, USA | 2: Preventice | None | 1: BIOTRONIK; 1: Boston Scientific; 1: Medtronic; 1: Toyota | None | None | None | None | 1: Preventice (Travel/Entertainment) |
Janet K. Han, MD, FHRS, FACC | VA Greater Los Angeles Healthcare System and David Geffen School of Medicine at the University of California, Los Angeles, Los Angeles, CA, USA | 1: Abbott; 1: Medtronic | None | None | None | None | None | None | None |
Hein Heidbuchel, MD, PhD, FESC, FEHRA | Antwerp University and University Hospital, Antwerp, Belgium | None | None | None | None | None | None | None | None |
He Huang, MD, FACC, FESC, FEHRA | Renmin Hospital of Wuhan University, Wuhan, China | None | None | None | None | None | None | None | None |
Dhanunjaya R. Lakkireddy, MD, FHRS, FACC | Kansas City Heart Rhythm Institute and Research Foundation, Overland Park, KS, USA | 1: BIOTRONIK; 2: Abbott | 1: Abiomed; 1: Biosense Webster; 1: Boston Scientific; 2: Janssen | None | None | None | None | None | None |
Tachapong Ngarmukos, MD, FAPHRS, FACC | Faculty of Medicine Ramathibodi Hospital, Mahidol University, Bangkok, Thailand | 1: Abbott; 1: Bayer; 1: Biosense Webster; 1: BIOTRONIK; 1: Boehringer Ingelheim; 1: Boston Scientific; 1: Daiichi Sankyo; 1: Medtronic; 1: Pfizer | None | None | None | None | None | None | None |
Andrea M. Russo, MD, FHRS, FACC | Cooper Medical School of Rowan University, Camden, NJ, USA | None | None | 1: MediLynx; 2: Boehringer Ingelheim; 2: Boston Scientific | None | None | None | 1: UpToDate | 0: ABIM (Member, ABIM Cardiovascular Board); 0: Apple Inc. (Steering Committee Apple Heart Study); 0: Boston Scientific (Steering Committee, Research) |
Eduardo B. Saad, MD, PhD, FHRS, FESC | Hospital Pró-Cardíaco, Rio de Janeiro, Brazil | 1: Biosense Webster | None | None | None | None | None | None | 1: Abbott (Travel/Entertainment) |
Luis C. Saenz Morales, MD | CardioInfantil Foundation, Cardiac Institute, Bogota, Colombia | None | None | None | None | None | None | None | None |
Kristin E. Sandau, PhD, RN | Bethel University, St. Paul, MN, USA | 1: Japanese Association of Cardiovascular Nursing | None | None | None | None | None | None | 1: Patient Safety Authority |
Arun Raghav M. Sridhar, MD, MPH, FACC | University of Washington, Seattle, WA, USA | None | None | None | None | None | None | None | None |
Eric C. Stecker, MD, MPH, FACC | Oregon Health & Science University, Portland, OR, USA | None | None | 4: AHA | None | None | None | None | None |
Paul D. Varosy, MD, FHRS, FACC | VA Eastern Colorado Health Care System and University of Colorado, Aurora, CO, USA | None | None | 4: NIH | None | None | None | None | 0: ACC (Committee Chair); 0: AHA (Committee Member); 0: NCDR (Committee Chair/Member) |
Number value: 0 = $0; 1 = ≤$10 000; 2 = >$10 000 to ≤$25 000; 3 = >$25 000 to ≤$50 000; 4 = >$50 000 to ≤$100 000; 5 = >$100 000.
Research and fellowship support are classed as programmatic support. Sources of programmatic support are disclosed but are not regarded as a relevant relationship with industry for writing group members or reviewers.
ABIM, American Board of Internal Medicine; ACC, American College of Cardiology; AHA, American Heart Association; NCDR, National Cardiovascular Data Registry; NIH, National Institutes of Health.